Rolph Timothy bought AKRO
October 7, 2025 · Form 4 insider transaction
Rolph Timothy bought 12,500 shares of Akero Therapeutics, Inc. at $28.35 per share, a transaction worth $354.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$28.35
Total value
$354.4K
InsiderRolph Timothy
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 7, 2025
Filing dateOctober 9, 2025
Shares owned after179,071
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 12, 2024, previously adopted by the Reporting Person.